HPSE and COVID-19: We next compared activity levels of GAG-degrading enzymes in non-ICU– and ICU-admitted patients with COVID-19 and observed that ICU-admitted patients show elevated circulating hyaluronidase (Figure 2D) and heparanase (Figure 2E), as well as a trend toward increase in chondroitinase activity (Figure 2F).